Belkin Michael
In this database
8
2015 โ 2025
DB Citations
63
across indexed articles
h-index
โ
Not available
Total Citations
โ
Not available
8 articles in Glaucoma Journal Club
Transscleral Selective Laser Trabeculoplasty Without a Gonioscopy Lens.
SLT applied directly to the perilimbal sclera may be as efficacious as the conventional procedure for 1 year.
Automated Direct Selective Laser Trabeculoplasty: First Prospective Clinical Trial.
Automated DSLT appears to be an effective and safe noncontact, rapid modality for reducing IOP in patients with OAG. Higher energy usage led to better results.
Energy Dose-Response in Selective Laser Trabeculoplasty: A Review.
The optimal energy level of SLT needed for IOP reduction has not yet been definitively established, with all reported pulse energies resulting in similar IOP reduction.
Investigating the neuroprotective effect of Copolymer-1 in acute primary angle closure - Interim report of a randomized placebo-controlled double-masked clinical trial.
After APAC, there was no difference in VF progression (or RNFL thickness change) between Cop-1 and placebo groups. However, there was improvement of MD in Cop-1 treated patients.
Randomized Noninferiority Trial of Direct Selective Laser Trabeculoplasty in Open-Angle Glaucoma and Ocular Hypertension: GLAUrious Study.
The 6-month primary end point did not achieve statistical noninferiority compared with conventional SLT.
A Proposal for the Use of a Fixed Low-Energy Selective Laser Trabeculoplasty for Open Angle Glaucoma.
Despite these variations in laser parameters, SLT consistently reduces IOP with a low complication rate.
Glaucoma Publication Trends in Leading General Ophthalmology Journals During the Past Quarter Century: Where Are the Clinical Trials?
There has been a significant rise in the rates of glaucoma publications in "experimentally oriented" journals, while their representation in "clinically oriented" journals remained stable over the past quarter century.
Efficacy of selective laser trabeculoplasty in primary angle-closure glaucoma: a randomized clinical trial.
Eyes with PAC or PACG respond to SLT in the short term, but the overall long-term therapeutic effectiveness needs further evaluation.